Selpercatinib (LOXO-292) in patients with RET-fusion+ non small-cell lung cancer (NSCLC) Meeting Abstract


Authors: Goto, K.; Oxnard, G.; Tan, Dswsw; Loong, H. H. F.; Bauer, T. T.; Gainor, J.; McCoach, C.; Gautschi, O.; Besse, B.; Cho, B. C.; Peled, N.; Weiss, J.; Kim, Y.; Ohe, Y.; Horiike, A.; Park, K.; Huang, X.; Olek, E.; Subbiah, V.; Drilon, A.; Wolf, J.
Abstract Title: Selpercatinib (LOXO-292) in patients with RET-fusion+ non small-cell lung cancer (NSCLC)
Meeting Title: Congress of the German Society for Pulmonology and Respiratory Medicine
Journal Title: Pneumologie
Volume: 75
Issue: Suppl. 1
Meeting Dates: 2021 Jun 2-10
Meeting Location: Virtual
ISSN: 0934-8387
Publisher: Georg Thieme Verlag Kg  
Date Published: 2021-04-01
Start Page: S42
Language: English
ACCESSION: WOS:000645825800074
DOI: 10.1055/s-0041-1723343
PROVIDER: wos
Notes: Meeting Abstract: P716 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    633 Drilon